Lipid Metabolism and Oxidative Stress in Uterine Corpus Endometrial Carcinoma: Prognostic and Immune Landscape Analysis
Asia-Pacific Journal of Clinical Oncology · 06.04.2026
DOI: 10.1111/ajco.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 06.04.2026. Verfasst von Hongfeng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics And Gynecology, the Affiliated People's Hospital of Ningbo University, Ningbo City, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Medical and Health Science and Technology Project of Zhejiang Province, Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project.
Abstract (Originalsprache)
Objective
Uterine corpus endometrial carcinoma (UCEC) is a common gynecologic malignancy characterized by metabolic reprogramming and immune dysregulation. This study aimed to investigate the prognostic and diagnostic value of lipid metabolism‐ and oxidative stress–related genes (LMOSGs) in UCEC.
Methods
Transcriptomic and clinical data from The Cancer Genome Atlas and Gene Expression Omnibus were analyzed to identify differentially expressed LMOSGs associated with prognosis using univariate Cox regression. Molecular subtypes were defined by non‐negative matrix factorization (NMF) clustering. Functional differences between subtypes were evaluated through Gene Ontology/Kyoto Encyclopedia of Genes and Genomes enrichment, immune cell infiltration analysis, and tumor microenvironment scoring. Prognostic genes were further refined using Least Absolute Shrinkage and Selection Operator regression to construct a risk signature. Gene expression was validated by reverse transcription quantitative real‐time polymerase chain reaction, the Human Protein Atlas, and single‐cell RNA sequencing data. A diagnostic model was developed using 12 machine learning algorithms. In vitro functional assays were conducted to assess the effects of key LMOSGs on cell proliferation, migration, and invasion.
Results
Fifty‐nine LMOSGs were identified as significantly associated with prognosis. NMF clustering classified UCEC into two molecular subtypes with distinct immune landscapes and survival outcomes: Cluster 1 exhibited higher immune infiltration and a favorable prognosis, whereas Cluster 2 showed immune suppression and poorer survival. A robust 10‐gene prognostic signature (PHGDH, MAPT, KCNK9, EPHX2, LIPH, SLC8A1, CREB3L4, PDCD1, MYLIP, and ORMDL2) demonstrated strong predictive performance. Among these, EPHX2, SLC8A1, ORMDL2, and MYLIP showed superior diagnostic discrimination and were further validated functionally as key regulators of tumor progression.
Conclusion
LMOSGs play critical roles in UCEC heterogeneity, prognosis, and immune modulation. These genes represent promising biomarkers and potential targets for personalized therapeutic strategies. Trial Registration Not applicable.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Obstetrics And Gynecology, the Affiliated People's Hospital of Ningbo University, Ningbo City, China.
Förderung
- Medical and Health Science and Technology Project of Zhejiang Province
- Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project
Zitieren
APA
Li, H., Bian, J., Zhang, Q., Du, Q., Wang, Y., Shang, Y., & Li, X. (2026). Lipid Metabolism and Oxidative Stress in Uterine Corpus Endometrial Carcinoma: Prognostic and Immune Landscape Analysis. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.70109
Vancouver
Li H, Bian J, Zhang Q, Du Q, Wang Y, Shang Y, et al. Lipid Metabolism and Oxidative Stress in Uterine Corpus Endometrial Carcinoma: Prognostic and Immune Landscape Analysis. Asia-Pacific Journal of Clinical Oncology. 2026. doi:10.1111/ajco.70109
BibTeX
@article{Li2026,
author = {Li, Hongfeng and Bian, Jia and Zhang, Qinwei and Du, Qiao and Wang, Yijie and Shang, Yaping and Li, Xuehe},
title = {Lipid Metabolism and Oxidative Stress in Uterine Corpus Endometrial Carcinoma: Prognostic and Immune Landscape Analysis},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
doi = {10.1111/ajco.70109}
}
EUVIMED